| Literature DB >> 19395675 |
Jason M Foulks1, Gopal K Marathe, Noemi Michetti, Diana M Stafforini, Guy A Zimmerman, Thomas M McIntyre, Andrew S Weyrich.
Abstract
Platelet activating factor (PAF) and PAF-like lipids induce inflammatory responses in target cells. These lipid mediators are inactivated by PAF-acetylhydrolase (PAF-AH). The PAF signaling system affects the growth of hematopoietic CD34(+) cells, but roles for PAF-AH in this process are unknown. Here, we investigated PAF-AH function during megakaryopoiesis and found that human CD34(+) cells accumulate this enzymatic activity as they differentiate toward megakaryocytes, consistent with the expression of mRNA and protein for the plasma PAF-AH isoform. Inhibition of endogenous PAF-AH activity in differentiated megakaryocytes increased formation of lipid mediators that signaled the PAF receptor (PAFR) in fully differentiated human cells such as neutrophils, as well as megakaryocytes themselves. PAF-AH also controlled megakaryocyte alpha(IIb)beta(3)-dependent adhesion, cell spreading, and mobility that relied on signaling through the PAFR. Together these data suggest that megakaryocytes generate PAF-AH to modulate the accumulation of intracellular phospholipid mediators that may detrimentally affect megakaryocyte development and function.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19395675 PMCID: PMC2710923 DOI: 10.1182/blood-2008-11-186312
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113